XELLIA PHARMACEUTICALS USA, LLC
XELLIA PHARMACEUTICALS USA, LLC appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0756-2021, Class II) was initiated on August 6, 2021.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0756-2021 | Class II | Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile, Rx Only, For Intravenous Infusion O | August 6, 2021 |
| D-0757-2021 | Class II | Micafungin for Injection, 100 mg/vial, Single-Dose Vial, Sterile, Rx Only, For Intravenous Infusion | August 6, 2021 |